CDKN2A and cancer: Consistent with the mutual exclusive relationship between RB1 and CDKN2A gene alterations, the genes are inversely expressed in most cancers exhibiting frequent loss/mutation of RB1 (Fig. 1f and Supplementary Fig. 6).